SPECIFIC MONOCLONAL ANTIBODY 2C2 FOR THE DIAGNOSIS AND CHARACTERIZATION OF HUMAN AND ANIMAL MICROSPORIDIOSIS CAUSED BY SPECIES OF THE GENRE ENCEPHALITOZOON.
ES2324087A1
SPECIFIC MONOCLONAL ANTIBODY 2E5 FOR THE DIAGNOSIS AND CHARACTERIZATION OF HUMAN AND ANIMAL MICROSPORIDIOSIS CAUSED BY ENCEPHALITOZOON INTESTINALIS.
ES2307462A1
DERIVATIVES OF NAFTOFURAN AND NAFTOTIOPHENE AS ANTIPROLIFERATIVE AGENTS OF CANCER DE PANCREAS AND COLON.
ES2316308A1
METRONIDAZOL BASED DRUG AND AZELAIC ACID FOR THE TOPICAL TREATMENT OF THE ROSACEA DISEASE OF BETTER ASSIMILATION, AND PREPARATION PROCEDURE.
ES2329643A1
PSEUDOMONAS SP. PME 707 (CECT 7314) GRINDER OF OILY WASTE FROM THE FOOD AND HOTEL INDUSTRY, AND PROCEDURE FOR APPLICATION.
ES2315205A1
BACILLUS AMYLOLIQUEFACIENS BAM 2507 (CECT 7313) GRINDER OF OILY WASTE FROM THE FOOD AND HOTEL INDUSTRY, AND PROCEDURE FOR APPLICATION.
ES2300229A1
BACILLUS SUBTILIS BL 1808 (CECT 7312) MADERON DEGRADER AND PROCEDURE FOR APPLICATION.
ES2288450A1
PLEIOTROPHIN (PTN) AND MIDKINA (MK) FOR THE TREATMENT OF TOXICITY PRODUCED BY ABUSE DRUGS.
ES2269004A1
USE OF ARTHROBACTER OXIDANS BB1 AS A PROTECTOR AGAINST SALINE STRESS.
ES2258415A1
BOBEL-24 (2,4,6-TRYODOPHENOL) FOR THE TREATMENT OR PREVENTION OF HUMAN AND ANIMAL CRYPTOSPORIDIOSIS.
ES2323200A1
METHOD FOR THE IDENTIFICATION OF MATERNAL LINES OF PERDIZ RIOJA (RUFA ALECTORIS), TURK PARK (CHUKAR ALECTORIS) AND GREEK PARADISE (GRAQUE ALECTORIS).
ES2249173A1
NEW PROCEDURE FOR THE STORAGE OF CARBON MONOXIDE BY ADSORTION IN ZEOLITES AND ITS APPLICATION TO THE CATALITIC PAUSON-KHAND REACTION.
ES2191532A1
DERIVATIVES OF HETEROCICLIC NAFTALIMIDS AS ANTIPROLIFERATIVE AGENTS.
ES2172474A1
GLUTARIMIDE DERIVATIVES AS THERAPEUTIC AGENTS.
ES2189597A1
DERIVATIVES OF 12,13-DIHIDRO-5H-INDOLO (2,3-A) PIRROLO (3,4-C) CARBAZOL-5,7 (6H) -DIONA AS ANTINEOPLASIC AGENTS.
